From: The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS
 | Baseline | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
---|---|---|---|---|---|---|
EDSS and Annualized Relapse Rate | X | X | X | X | X | X |
Multiple Sclerosis Functional Composite | X | X | X | X | Â | X |
Quality of Life (SF-36, NEI-VFQ-25 + 10S1) | X |  |  | X |  | X |
Anxiety and Depression assessment1 | X | Â | Â | X | Â | X |
Neuropsychological Battery (BRB-N) | X | Â | X | Â | Â | X |
High (EDTRS) and Low (LCSLC) VA | X | X | X | X | X | X |
Color vision test (HRR plates) | X | X | X | X | X | X |
Visual Fields | X | X | Â | Â | Â | X |
Indirect Funduscopy - Optomap2002 | X | X | X | X | X | X |
Multifocal Visual Evoked Potentials2 | X | X | X | X | X | X |
Optical Coherence Tomography | X | X | X | X | X | X |
Magnetic Resonance Imaging | X | X | X | X | X | X |